- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02501577
Comparison of Various Supraglottic Airway Devices for Fiberoptical Guided Tracheal Intubation (supraview)
July 16, 2015 updated by: Thomas Metterlein, University of Regensburg
Placement of a supraglottic airway device Fiberoptical verification of pharyngeal position
Study Overview
Status
Unknown
Conditions
Intervention / Treatment
Detailed Description
Feasibility for fiberoptical verification of pharyngeal position of supraglottic airway device
Study Type
Interventional
Enrollment (Anticipated)
30
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Thomas Metterlein, MD
- Phone Number: +499419440
- Email: thomas.metterlein@ukr.de
Study Contact Backup
- Name: Christoph Plank, MD
- Phone Number: +499419440
- Email: christop.plank@ukr.de
Study Locations
-
-
-
Regensburg, Germany, 93051
- Recruiting
- University Regensburg
-
Contact:
- Thomas Metterlein, MD
- Phone Number: +499419440
- Email: thomas.metterlein@ukr.de
-
Contact:
- Christoph Plank, MD
- Phone Number: +499419440
- Email: christoph.plank@ukr.de
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 80 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- will to participate
Exclusion Criteria:
- none
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: SAD 1
FOI for placement
|
Placement and fiberoptic control
|
Experimental: SAD 2
FOI für placement
|
Placement and fiberoptic control
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Visibility of vocal cords
Time Frame: intraoperative
|
intraoperative
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Study Chair: Thomas Metterlein, MD, Uni Regensburg
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
March 1, 2015
Primary Completion (Anticipated)
October 1, 2015
Study Completion (Anticipated)
October 1, 2015
Study Registration Dates
First Submitted
July 9, 2015
First Submitted That Met QC Criteria
July 16, 2015
First Posted (Estimate)
July 17, 2015
Study Record Updates
Last Update Posted (Estimate)
July 17, 2015
Last Update Submitted That Met QC Criteria
July 16, 2015
Last Verified
July 1, 2015
More Information
Terms related to this study
Other Study ID Numbers
- sadfoi
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Intubation; Difficult
-
Lazarski UniversityCompletedIntubation; Difficult or Failed | Difficult Airway | Intubation;DifficultPoland
-
Catharina Ziekenhuis EindhovenCompletedAnesthesia Intubation Complication | Intubation; Difficult | Failed or Difficult Intubation | Failed or Difficult Intubation, Initial EncounterNetherlands
-
Michael MaRecruitingDifficult Intubation | Difficult Airway IntubationIreland
-
Children's Hospital of PhiladelphiaEunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaboratorsCompletedIntubation Complication | Intubation;Difficult | Failed or Difficult Intubation, SequelaUnited States, Canada, Singapore
-
Children's Hospital of PhiladelphiaAgency for Healthcare Research and Quality (AHRQ)RecruitingIntubation Complication | Intubation; Difficult | Failed or Difficult Intubation, SequelaUnited States, Canada, Japan, Italy, New Zealand, Singapore, Australia, Austria, Germany, India, United Kingdom
-
J. Matthias WalzTerminatedSurgery | Difficult Intubation | Anesthesia | Difficult Airway Intubation | Speech DysfunctionUnited States
-
Derince Training and Research HospitalCompletedDifficult Intubation | Difficult AirwayTurkey
-
University at BuffaloTerminatedIntubation Complication | Intubation;DifficultUnited States
-
University Hospitals Coventry and Warwickshire...Oxford University Hospitals NHS TrustCompletedIntubation;Difficult | Tracheal IntubationUnited Kingdom
-
Heinrich-Heine University, DuesseldorfCompleted
Clinical Trials on SAD 1
-
Chiesi Farmaceutici S.p.A.CompletedCystic Fibrosis | Non-Cystic Fibrosis BronchiectasisBelgium
-
Nanjing RegeneCore Biotech Co., Ltd.Recruiting
-
Hoffmann-La RocheCompletedHealthy VolunteerNew Zealand
-
Vigonvita Life SciencesRecruiting
-
Beijing Suncadia Pharmaceuticals Co., LtdActive, not recruitingPrevention of Arterial and Venous ThrombosisChina
-
Inmagene LLCRecruiting
-
Shanghai Jiatan Pharmatech Co., LtdCompleted
-
Galapagos NVCompleted
-
Dongguan HEC TaiGen Biopharmaceuticals Co., Ltd.R&G Pharma Studies Co.,Ltd.CompletedHealthy Chinese VolunteersChina
-
University of VermontUniversity of Pittsburgh; University of Maryland School of MedicineActive, not recruitingSeasonal Affective DisorderUnited States